Current pharmacotherapeutical options for the prevention of kidney transplant rejection

Author： Schaefer Sebastian M Süsal Caner Sommerer Claudia Zeier Martin Morath Christian

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.8, 2013-06, pp. : 1029-1041

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunosuppressive strategies for prevention of transplant rejection

By Dumont F.J.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 3, 2001-03 ,pp. : 377-404

Informa Healthcare

Access to resources Recommend Favorite

Tripterygium wilfordii Hook F is effective in the prevention of acute kidney transplant rejection and improves long-term graft survival rates

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Anti-Interleukin-2 Receptor Antibodies for the Prevention of Rejection in Pediatric Renal Transplant Patients: Current Status

By Swiatecka-Urban A.

Pediatric Drugs, Vol. 5, Iss. 10, 2003-01 ,pp. : 699-716

Adis International

Access to resources Recommend Favorite

Bortezomib in Kidney Transplant: Current Use and Perspectives

Current Drug Metabolism, Vol. 18, Iss. 12, 2018-02 ,pp. : 1136-1146

Bentham Science Publishers

Access to resources Recommend Favorite

Mycophenolate Sodium Delayed Release: Prevention of Renal Transplant Rejection

By Curran Monique P. Keating Gillian M.

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 799-805

Adis International

Access to resources Recommend Favorite